Aurinia Pharmaceuticals
AUPH
#4600
Rank
C$2.88 B
Marketcap
C$21.87
Share price
2.65%
Change (1 day)
52.88%
Change (1 year)

Earnings for Aurinia Pharmaceuticals (AUPH)

Earnings in 2025 (TTM): C$0.11 Billion

According to Aurinia Pharmaceuticals 's latest financial reports the company's current earnings are C$0.26 Billion. In 2024 the company made an earning of C$16.91 Million, an increase over its 2023 earnings that were of -C$0.11 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Aurinia Pharmaceuticals from 1999 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) C$0.11 B595.24%
2024 C$16.91 M-116.44%
2023 -C$0.11 Billion-31.8%
2022 -C$0.16 Billion-39.4%
2021 -C$0.25 Billion61.9%
2020 -C$0.16 Billion-9.73%
2019 -C$0.18 Billion92.65%
2018 -C$88.4 Million36.39%
2017 -C$64.82 Million106.29%
2016 -C$31.42 Million-15.4%
2015 -C$37.14 Million65.84%
2014 -C$22.4 Million129.82%
2013 -C$9.75 Million-26.6%
2012 -C$13.28 Million
2010 -C$7.52 Million-39.22%
2009 -C$12.37 Million-43.78%
2008 -C$22 Million-53.19%
2007 -C$47 Million42.97%
2006 -C$32.87 Million-23.03%
2005 -C$42.71 Million36.1%
2004 -C$31.38 Million172.57%
2003 -C$11.52 Million484.61%
2002 -C$1.97 Million
2000 -C$9.35 Million453.81%
1999 -C$1.69 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Regeneron Pharmaceuticals
REGN
C$7.08 B 6,020.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Aeterna Zentaris
AEZS
-C$7.56 Million-106.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Pieris Pharmaceuticals
PIRS
-C$30.47 Million-126.31%๐Ÿ‡บ๐Ÿ‡ธ USA